Australia - Inggris - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - meropenem trihydrate, quantity: 570.78 mg - injection, powder for - excipient ingredients: sodium carbonate - meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:. - community acquired lower respiratory tract infection. - hospital acquired lower respiratory tract infection. - complicated urinary tract infection. - febrile neutropenia . - intra-abdominal and gynaecological (poly microbial) infections. - complicated skin and skin structure infections. - meningitis. - septicaemia.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - meropenem trihydrate, quantity: 1.1415 g - injection, powder for - excipient ingredients: sodium carbonate - meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:. - community acquired lower respiratory tract infection. - hospital acquired lower respiratory tract infection. - complicated urinary tract infection. - febrile neutropenia . - intra-abdominal and gynaecological (poly microbial) infections. - complicated skin and skin structure infections. - meningitis. - septicaemia.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - meropenem trihydrate 1140mg equivalent to meropenem 1 g - powder for injection - 1 g - active: meropenem trihydrate 1140mg equivalent to meropenem 1 g excipient: sodium carbonate - for treatment, in adults and children, of the following infections caused by single or multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms: - lower respiratory tract infections - urinary tract infections, including complicated infections - intra-abdominal infections - gynaecological infections, including postpartum infections - skin and skin structure infections - meningitis - empiric treatment, including initial monotherapy, for presumed bacterial infections in host-compromised, neutropenic patients -septicaemia

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - meropenem trihydrate 570mg equivalent to meropenem 500 mg - powder for injection - 500 mg - active: meropenem trihydrate 570mg equivalent to meropenem 500 mg excipient: sodium carbonate - for treatment, in adults and children, of the following infections caused by single or multiple susceptible bacteria and as empiric therapy prior to the identification of the causative organisms: - lower respiratory tract infections - urinary tract infections, including complicated infections - intra-abdominal infections - gynaecological infections, including postpartum infections - skin and skin structure infections - meningitis - empiric treatment, including initial monotherapy, for presumed bacterial infections in host-compromised, neutropenic patients -septicaemia

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bradex s.a. - meropenem trihydrate 570 mg - eq. meropenem anhydrous 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570 mg - meropenem

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bradex s.a. - meropenem trihydrate 1140 mg - eq. meropenem anhydrous 1000 mg - powder for solution for injection/infusion - 1 g - meropenem trihydrate 1140 mg - meropenem

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - meropenem trihydrate 570 mg - eq. meropenem 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570 mg - meropenem

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - meropenem trihydrate 1140 mg - eq. meropenem 1000,1 mg - powder for solution for injection/infusion - 1 g - meropenem trihydrate 1140 mg - meropenem

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ranbaxy (uk) (5) ltd. - meropenem trihydrate 570 mg - eq. meropenem anhydrous 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570 mg - meropenem

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ranbaxy (uk) (5) ltd. - meropenem trihydrate 1140 mg - eq. meropenem anhydrous 1000 mg - powder for solution for injection/infusion - 1 g - meropenem trihydrate 1140 mg - meropenem